Faculty

Institution

Unit

Venue

Kenneth Boucher

Research Associate Professor

University of Utah

Affiliations

Spencer Fox Eccles School of Medicine

Population Health Sciences

Kenneth Boucher is currently serving as a Population Health Sciences Research Associate Professor at University of Utah.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Kenneth Boucher

University of Utah

Research Associate Professor

You can click a keyword to filter the displayed items

oncology cancer research pharmacology health sciences medicine cancer treatment cancer care clinical research genetics medicinal research cancer biology colorectal cancer tumor biology hematology melanoma pharmacotherapy anti-cancer agents surgical oncology cancer genomics gastroenterology cancer genetics hepatology cancer management genitourinary cancers clinical epidemiology medical genetics cancer risk cancer imaging cancer prevention skin cancer molecular cancer genome biology clinical gastroenterology population-based study molecular diagnostics pancreatic cancer pancreatic adenocarcinoma melanocytic nevi mathematical bioscience enzyme inhibition disease risk assessment clinical evidence drug targeting phase ii study digestive diseases respiratory medicine tumor targeting pilot study phase ii experimental medicine oncogenes preventive medicine breast surgery reconstructive surgery cutaneous biology radiation therapy clinical investigation randomized controlled trials clinical implementation breast oncology genomic medicine tumor suppressors prognostic biomarkers familial risk microarray data analysis liver cancer anticoagulants colon cancer stereotactic radiosurgery mtor inhibitors lynch syndrome brain metastases systematic review familial adenomatous polyposis melanoma brain metastases pediatric patients cancer letter biomedical informatics biomedical data science biostatistics systems biology cancer biostatistics translational bioinformatics

Notable Scholarly Works

Notable Federal Grants

Collaborators

A Prospective Trial of a Structured Exercise Program to Lessen Fatigue in Patients With Advanced Prostate Cancer (Apc) Undergoing Androgen Deprivation Therapy (Adt).. Journal of Clinical Oncology (2025)

Benjamin L. MaughanNeeraj AgarwalDarren WalkerAdriana M ColettaBlake NordbladUmang SwamiSumati GuptaSaundra S. BuysManish KohliPamela A HansenKenneth M BoucherNorah Lynn Henry

exercise physiologyadvanced prostate cancerandrogen deprivation therapyprospective trialsurgical oncologyexercise sciencethoracic oncologyphysical fitnesscardiovascular fitnessphysiologyfatigue managementprostatic diseaseapplied physiologyneurorehabilitationprostate cancerstructured exercise programurologyrehabilitationexercise rehabilitationphysical exerciseoncology

Cabozantinib Plus Pembrolizumab as First-Line Therapy for Cisplatin-Ineligible Advanced Urothelial Carcinoma: The Pemcab Trial. European Urology Oncology (2025)

Rohit K JainUmang SwamiMehmet A BilenGeorges GebraelKenneth M BoucherEmma BraunJacqueline T BrownJad ChahoudSumati GuptaNeeraj AgarwalGuru SonpavdeBenjamin L Maughan

prospective cohort studiestherapy resistancegliomasimmunologyfirst-line therapytherapeutic targetsbreast cancerretrospective cohort studiesnovel therapieslung canceroncogenespemcab trialmedicinal researchcellular therapysystems biologyneurologyoncologybrain tumor researchleukemiatherapeutic efficacy

Nivolumab Adjuvant to Chemo-Radiation in Localized Muscle-Invasive Urothelial Cancer: Primary Analysis of a Multicenter, Single-Arm, Phase II, Investigator-Initiated Trial (Next). Journal for ImmunoTherapy of Cancer (2025)

Gliceida M Galarza FortunaDaniel GrassBenjamin L MaughanRohit K JainChristopher DechetJulia BeckEkke SchuetzAlejandro SanchezBrock O'NeilMichael PochRoger LiShane LloydJonathan TwardTenzin PhunrabJosiah Lyn HawksUmang SwamiKenneth M BoucherNeeraj AgarwalSumati Gupta

urogynecologycancer discoverypharmacologytherapeutic targetsthoracic oncologyprimary investigationtumor biologynephrologyradiologycancer researchpharmacotherapycancer treatmentmedicinal researchprimary analysisphase iikey sitetumor targetingradiation therapy planninginvestigator-initiated trialbiomedical engineeringoncology

Phase II Trial of Image-Guided Oligometastatectomy and Radiation Therapy in Recurrent Prostate Cancer (Soar).. Journal of Clinical Oncology (2025)

Alejandro SanchezUmang SwamiBogdana SchmidtChristopher B. DechetKenneth M BoucherLisa ChapmanHillary DavisJeff LintonErica FarrSamuel LeonhartJosiah HawksSkyler B JohnsonJonathan David TwardBismarck OdeiSumati GuptaNeeraj AgarwalBrock ONeilBenjamin L. Maughan

clinical radiation oncologyradiation therapyradiation oncologymri-guided radiation therapymedical imagingsurgical oncologyimage-guided oligometastatectomyprostate cancerradiologycancer imagingcancer researchoncologic imagingrecurrent prostate cancerphase ii trialclinical researchurologyoncologyimage-guided interventions

Pro-XL: A Phase II Study of Zanzalintinib (Xl092) in Patients With Metastatic Castration-Resistant Prostate Cancer (Mcrpc) After Progression on Lutetium-177 (177Lu)-Psma-617.. Journal of Clinical Oncology (2025)

Umang SwamiKenneth M BoucherYeonjung JoColin MoynierSusan ClementTenzin Kunsang PhunrabJulia BattenJoshua QuertinmontJon MahlowVinay Mathew ThomasSumati GuptaManish KohliBenjamin L. MaughanNeeraj Agarwal

metastasismeso levelprostate cancerdrug resistancecancer researchclinical researchurologyphase ii study

Recurrence of Cutaneous Squamous Cell Carcinoma in Situ With Follicular Involvement. Journal of the American Academy of Dermatology (2025)

Nathan ShenAusten CallisterScott R FlorellAbigail FlorellKenneth M BoucherAlice FrigerioDouglas Grossman

gynecologic oncologypathologycohort studiestumor biologyfollicular involvementdermatopathologyskin cancerdermatologysurgical pathologygynecologycarcinogenesishistopathologycancer discoverycutaneous biologygynecologic cancersclinical dermatologycancer cellstumor microenvironment

Abstract 7349: Ligand-Receptor Signaling Analysis and Tumor-Immune Microenvironment Deconvolution Reveal Differential Adipose-Tumor Crosstalk in Lean and Obese Colon Cancer Patients. Cancer Research (2024)

Tengda LinVictoria M. BanderaElaine M. GlennyCaroline HimbertJennifer OseChristy WarbyOlena AksonovaAlessandro CarpaneseChris StubbenDavid NixKenneth M. BoucherPeter SchirmacherIldiko StrehliJolanta JedrzkiewiczCourtney L. ScaifeBartley PickronAlexander BrobeilMartin SchneiderChristoph KahlertErin M. SiegelAdetunji T. ToriolaDavid ShibataChristopher I. LiJane C. FigueiredoJatin RoperBiljana GigicStephen D. HurstingCornelia M. UlrichAik Choon Tan

colorectal cancervascular biologytumor biologycancer immunotherapyimmunologymedicinal researchsurgical oncologydermatologymolecular cancercancer researchcancer genomicspharmacologycancer managementclinical researchcancer treatmentcancer careoncologycancer biology

A Phase II Study of Rucaparib Monotherapy in Nonmetastatic, Hormone-Sensitive Prostate Cancer Demonstrating “Brcaness” Genotype (Roar). The Oncologist (2024)

Kamal Kant SahuHaoran LiVinay Mathew ThomasMallory BensonKen BoucherSumati GuptaManish KohliUmang SwamiNeeraj AgarwalBenjamin L Maughan

neurologytumor biologyhormone-sensitive prostate cancernanomedicinecancer treatmentmedicinal researchprostate cancercancer researchrucaparib monotherapymedicineurologyenzyme inhibitioncancer careoncologyphase ii study

BORXPTEN: A Phase II Study of Bortezomib (B) in Patients (Pts) With Metastatic Castration-Resistant Prostate Cancer (Mcrpc) With Pten Deletion.. Journal of Clinical Oncology (2024)

Vinay Mathew ThomasColin MoynierKenneth M. BoucherBlake NordbladSusan ClementMichelle EsplinManish KohliSumati GuptaBenjamin L. MaughanNeeraj AgarwalUmang Swami

gynecologic oncologysurgical oncologygenitourinary cancerspharmacologythoracic oncologyphase ii studyradiologyprostatic diseasecancer researchtumor suppressorsbenign prostatic hyperplasiagastrointestinal oncologymedicinal researchprostate cancerpten deletionurologycancer caremetastasisclinical researchoncology

CABOLU: A Phase 1B Study of Cabozantinib (Cabo) in Combination With Lutetium (Lu 177) Vipivotide Tetraxetan (Lvt) in Patients (Pts) With Metastatic Castration-Resistant Prostate Cancer (Mcrpc).. Journal of Clinical Oncology (2024)

Gliceida Galarza FortunaColin MoynierKenneth M. BoucherBlake NordbladMatthew CovingtonGabriel FineSusan ClementMichelle EsplinManish KohliSumati GuptaBenjamin L. MaughanNeeraj AgarwalUmang Swami

neurologygastrointestinal oncologydrug targetinganti-cancer agentscancer treatmentprostate cancercancer researchpharmacologyvipivotide tetraxetanclinical researchurologypharmacotherapycancer careoncology

1
2
3
4
5
26
10 / page

Kenneth Boucher

Research Associate Professor

University of Utah

Affiliations

Spencer Fox Eccles School of Medicine

Population Health Sciences

Kenneth Boucher is currently serving as a Population Health Sciences Research Associate Professor at University of Utah.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Kenneth Boucher

University of Utah

Research Associate Professor

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Benjamin L. MaughanNeeraj AgarwalDarren WalkerAdriana M ColettaBlake NordbladUmang SwamiSumati GuptaSaundra S. BuysManish KohliPamela A HansenKenneth M BoucherNorah Lynn Henry

Cabozantinib Plus Pembrolizumab as First-Line Therapy for Cisplatin-Ineligible Advanced Urothelial Carcinoma: The Pemcab Trial. European Urology Oncology (2025)

Rohit K JainUmang SwamiMehmet A BilenGeorges GebraelKenneth M BoucherEmma BraunJacqueline T BrownJad ChahoudSumati GuptaNeeraj AgarwalGuru SonpavdeBenjamin L Maughan

Phase II Trial of Image-Guided Oligometastatectomy and Radiation Therapy in Recurrent Prostate Cancer (Soar).. Journal of Clinical Oncology (2025)

metastasismeso levelprostate cancerdrug resistancecancer researchclinical researchurologyphase ii study

Recurrence of Cutaneous Squamous Cell Carcinoma in Situ With Follicular Involvement. Journal of the American Academy of Dermatology (2025)

Nathan ShenAusten CallisterScott R FlorellAbigail FlorellKenneth M BoucherAlice FrigerioDouglas Grossman

A Phase II Study of Rucaparib Monotherapy in Nonmetastatic, Hormone-Sensitive Prostate Cancer Demonstrating “Brcaness” Genotype (Roar). The Oncologist (2024)

Kamal Kant SahuHaoran LiVinay Mathew ThomasMallory BensonKen BoucherSumati GuptaManish KohliUmang SwamiNeeraj AgarwalBenjamin L Maughan

BORXPTEN: A Phase II Study of Bortezomib (B) in Patients (Pts) With Metastatic Castration-Resistant Prostate Cancer (Mcrpc) With Pten Deletion.. Journal of Clinical Oncology (2024)

Vinay Mathew ThomasColin MoynierKenneth M. BoucherBlake NordbladSusan ClementMichelle EsplinManish KohliSumati GuptaBenjamin L. MaughanNeeraj AgarwalUmang Swami

Gliceida Galarza FortunaColin MoynierKenneth M. BoucherBlake NordbladMatthew CovingtonGabriel FineSusan ClementMichelle EsplinManish KohliSumati GuptaBenjamin L. MaughanNeeraj AgarwalUmang Swami

1
2
3
4
5
26
10 / page

Similar Faculty Members

Afshin Dowlati

Institution

Case Western Reserve University

cancer letter

bronchial neoplasm

Frank L. Meyskens

Institution

University of California, Irvine

oncology

cancer research

James Ford

Institution

Stanford University

personalized medicine

radiation oncology

Peter J. O'Dwyer

Institution

University of Pennsylvania

oncology

pharmacology

Lisa A. Carey

Institution

University of North Carolina at Chapel Hill

cancer letter

cancer treatment

Heather Wakelee

Institution

Stanford University

radiation oncology

mesothelioma

Barbara Burtness

Institution

Yale University

receptor tyrosine kinase

kras inhibition

Seongho Kim

Institution

Wayne State University

data analysis

personalized medicine

Janice Mehnert

Institution

New York University

tumor targeting

radiation oncology

Kazuaki Takabe

Institution

University at Buffalo

hepatology

pathology

Similar Faculty Members

Afshin Dowlati

Institution

Case Western Reserve University

cancer letter

bronchial neoplasm

Frank L. Meyskens

Institution

University of California, Irvine

oncology

cancer research

James Ford

Institution

Stanford University

personalized medicine

radiation oncology

Peter J. O'Dwyer

Institution

University of Pennsylvania

oncology

pharmacology

Lisa A. Carey

Institution

University of North Carolina at Chapel Hill

cancer letter

cancer treatment

Heather Wakelee

Institution

Stanford University

radiation oncology

mesothelioma

Barbara Burtness

Institution

Yale University

receptor tyrosine kinase

kras inhibition

Seongho Kim

Institution

Wayne State University

data analysis

personalized medicine

Janice Mehnert

Institution

New York University

tumor targeting

radiation oncology

Kazuaki Takabe

Institution

University at Buffalo

hepatology

pathology